Subscribe to Diagnostics
View Sample

FREE Email Newsletter

AdvaMedDx Supports Diagnostics Payment Reform Legislation

September 16, 2013 10:23 am | by AdvaMedDx | News | Comments

Andrew Fish, executive director of AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) focused on diagnostics policy matters, released the following statement on the introduction in the U.S. House of Representatives of the Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network (MODDERN) Cures Act.

Schizophrenia: It’s in the Wiring of the Brain

September 16, 2013 10:20 am | by Elsevier | News | Comments

Just as wires must be insulated to effectively carry electrical impulses, nerve cells must be insulated by myelin to effectively transmit neural impulses. Using typical magnetic resonance imaging or MRI, one can visually distinguish parts of the brain that look white and parts that look gray.

Scientists Creating New Diagnostic and Bioinformatics Tools for Psychotic Disorders

September 16, 2013 10:05 am | by Technical Research Centre of Finland (VTT) | News | Comments

A new EU project, METSY, develops and applies neuroimaging and bioinformatics tools to study how lipid metabolism is connected to psychotic disorders and metabolic co-morbidities such as metabolic syndrome and diabetes. The overall objective is to identify, prioritize and evaluate multi-modal blood and neuroimaging biomarkers...


Quidel Receives Two FDA Clearances for Molecular Diagnostic Tests for Use on Life Technologies QuantStudio(TM) Dx

September 16, 2013 8:00 am | by The Associated Press | News | Comments

Quidel Corporation and Life Technologies Corporation announced today that the United States Food and Drug Administration (FDA) has granted 510(k) clearances to the Quidel Molecular Influenza A+B assay and the Quidel Molecular RSV + hMPV assay, both for use on the QuantStudio™ Dx Real-Time PCR Instrument by Life Technologies.

Helping to Reduce Hospital Admissions for COPD Patients

September 13, 2013 10:41 am | by SINTEF | News | Comments

Product designer Jarl Reitan and his colleague Silje Bøthun are working on a preventative project for patients with advanced COPD. Five patients from Trondheim are currently testing a system using tablet computers and a customized app developed by SINTEF.

Association Between Virus, Bladder Cancers Detected Using Lawrence Livermore Technology

September 13, 2013 10:20 am | by Stephen P. Wampler, Lawrence Livermore National Laboratory | News | Comments

A Lawrence Livermore National Laboratory-developed biological detection technology has been employed as part of an international collaboration that has detected a virus in bladder cancers. The research is believed to be the first study to demonstrate an association between Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, and bladder cancers.

Catching the Silent Thief of Sight

September 12, 2013 11:04 am | by A-Star Research | News | Comments

A team of researchers led by Jun Cheng of the A*STAR Institute for Infocomm Research, Singapore, has developed a novel automated technology that screens for glaucoma more accurately and quickly than existing methods.      

The Menarini Group Acquires Silicon Biosystems

September 12, 2013 9:00 am | by Business Wire | News | Comments

The Menarini Group, a privately held Italian pharmaceutical and diagnostics company, today announced it has acquired Silicon Biosystems, S.p.A., a provider of specialized molecular and cellular biology technologies capable of recovering and analyzing tumor cells from blood samples.


Post-Operative Cancer Treatment and Chronic Wound Care Technology Concept Unveiled

September 11, 2013 10:20 am | by Neil Cooper, Team Consulting | News | Comments

Award-winning medical design and development company Team Consulting has today unveiled an innovative concept that has the potential to address two significant unmet clinical needs; early detection of cancer regrowth following surgery and detection of infection within chronic wounds.

Post-Operative Cancer Treatment Technology Unveiled

September 11, 2013 10:10 am | by Team Consulting | Videos | Comments

Award-winning medical design and development company Team Consulting has today unveiled an innovative concept that has the potential to address two significant unmet clinical needs; early detection of cancer regrowth following surgery and detection of infection within chronic wounds.

How the Smartphone Can Revolutionize Healthcare

September 10, 2013 3:15 pm | by Chet Kolley, Business Unit Vice President, GlobalLogic | Blogs | Comments

Over 200 million people have downloaded a healthcare application to their smartphone. However, only a small number of those downloaded apps are used regularly and, since most apps are free, even a smaller number of applications actually generate any revenue.

Damages to Organs Detected in 3D Holograms

September 10, 2013 10:35 am | by Investigación y Desarrollo | News | Comments

Recently converted in one of the youngest residents of Silicon Valley, California, the high-tech Mexican enterprise Echopixel created software that allows the medical doctor to look and manipulate on their desk third dimension (3D) holograms of various organs obtained from ultrasound, CT or MRI scans.

MRI May Predict Heart Attack and Stroke Risk in People with Diabetes

September 10, 2013 9:38 am | by Radiological Society of North America | News | Comments

Whole-body MRI may serve as a valuable noninvasive tool for assessing the risk of heart attack and stroke in diabetic patients, according to a new study published online in the journal Radiology. Diabetes is a metabolic disease characterized by an increased concentration of glucose in the blood.


NanoString Technologies Receives FDA 510(k) Clearance for Prosigna™ Breast Cancer Prognostic Gene Signature Assay

September 9, 2013 4:10 pm | by Business Wire | News | Comments

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Prosigna ™ Breast Cancer Prognostic Gene Signature Assay.

Capturing Brain Activity with Sculpted Light

September 9, 2013 12:16 pm | by Universität Wien | News | Comments

Researchers in Vienna develop new imaging technique to study the function of entire nervous systems Scientists at the Campus Vienna Biocenter have found a way to overcome some of the limitations of light microscopy. Applying the new technique, they can record the activity of a worm’s brain with high temporal and spatial resolution, ultimately linking brain anatomy to brain function.

New 'Artificial Nose' Device Can Speed Diagnosis of Sepsis

September 9, 2013 9:38 am | by American Chemical Society | News | Comments

Disease-causing bacteria stink — literally — and the odor released by some of the nastiest microbes has become the basis for a faster and simpler new way to diagnose blood infections and finger the specific microbe. The new test produces ...

Guided Therapeutics Receives Additional Questions from FDA for LuViva Advanced Cervical Scan

September 9, 2013 7:00 am | by Business Wire | News | Comments

Guided Therapeutics, Inc. today announced that the company received additional questions from the U.S. Food and Drug Administration (FDA) regarding the pre-market approval application for the LuViva ® Advanced Cervical Scan. FDA advised the company the PMA was not yet approvable in its current form and that the company needed to address these questions in order to place the PMA in approvable form.

Modeling the Electrochemistry of Blood Glucose Test Strips

September 6, 2013 3:09 pm | by Gary Dagastine | COMSOL, Inc. | Articles | Comments

Self-monitoring of blood glucose levels is vital to effective diabetes control, and so every day, diabetics around the world share the same routine: They place a drop of their blood on a test strip and insert the strip into a meter to measure their glucose level. But few of them probably stop to think that the humble little plastic test strip that makes self-monitoring possible is actually a highly engineered sensor.

Sensing a Healthcare Revolution

September 6, 2013 12:06 pm | by Mark Winter, Senior Director, Nokia Sensing XCHALLENGE and the Qualcomm Tricorder XPRIZE | Blogs | Comments

In today’s interconnected world, it’s easier to set a DVR from an airplane seat or remotely watch the kids arrive home than to gather significant data about our health. Traditional office visits, laboratory tests, and hospital-based equipment are still the primary means of acquiring information about a person’s health.

Enzymatics Acquires ArcherDx and Next-Generation Diagnostic Technology

September 6, 2013 7:30 am | by Business Wire | News | Comments

Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment. The deal consists of cash, equity and potential milestones worth up to $50 million.

Trovagene collaborates with USC in clinical study evaluating cancer monitoring technology

September 6, 2013 5:00 am | by The Associated Press | News | Comments

Trovagene, Inc., a developer of molecular diagnostics for cancer monitoring, today announced that the Company has entered into a clinical collaboration agreement with the University of Southern California to study genomic characterizations of metastatic colorectal cancers using Trovagene's proprietary cell-free DNA assays.

Siemens' high-risk recall affects more than 78,000 antimicrobial tests

September 5, 2013 1:59 pm | by Mass Device | News | Comments

FDA regulators put their highest-risk Class I label on Siemens' (NYSE:SI) recall of more than 78,000 of its MicroScan Synergies plus and MicroScan rapID/S plus antimicrobial tests, warning that false test results could hinder patient care.  

Abbott's Test May Offer More Accurate Diagnosis of Heart Attacks in Women

September 5, 2013 10:41 am | by Abbott | News | Comments

Abbott announced today promising preliminary results from a study presented at the ESC Congress 2013, suggesting that its high sensitive troponin test may help doctors improve the diagnosis and prognosis of patients presenting with symptoms of a heart attack.

ADVANCE Medical Closes US $20 Million Equity Financing

September 4, 2013 11:03 am | by The Associated Press | News | Comments

ADVANCE Medica has announced it has raised US$20 million in an equity financing from new investors Aberdare Ventures and Arboretum Ventures, as well as existing investors including Venrock and Jose Bonchristiano. ADVANCE Medical also announced it has reached a definitive agreement to acquire all of the outstanding shares of Imunotech Sistemas Diagnosticos...

New Method for Early Detection of Colon Cancer

September 4, 2013 12:05 am | by AACR | News | Comments

A new, highly sensitive method to detect genetic variations that initiate colon cancer could be readily used for noninvasive colon cancer screening, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.